Home » Astellas to Buy Japanese, Other Rights to IBS Drug
Astellas to Buy Japanese, Other Rights to IBS Drug
Astellas Pharma, Japan’s No. 2 drugmaker, said it will buy the rights to develop and sell U.S. firm Ironwood Pharmaceuticals’ drug
for irritable bowel syndrome in Japan and other parts of Asia.
CNBC
CNBC
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May